1. Home
  2. RCEL vs VABK Comparison

RCEL vs VABK Comparison

Compare RCEL & VABK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • VABK
  • Stock Information
  • Founded
  • RCEL N/A
  • VABK 1998
  • Country
  • RCEL United States
  • VABK United States
  • Employees
  • RCEL N/A
  • VABK N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • VABK Major Banks
  • Sector
  • RCEL Health Care
  • VABK Finance
  • Exchange
  • RCEL Nasdaq
  • VABK Nasdaq
  • Market Cap
  • RCEL 227.5M
  • VABK 206.0M
  • IPO Year
  • RCEL N/A
  • VABK N/A
  • Fundamental
  • Price
  • RCEL $9.21
  • VABK $34.62
  • Analyst Decision
  • RCEL Strong Buy
  • VABK
  • Analyst Count
  • RCEL 4
  • VABK 0
  • Target Price
  • RCEL $17.25
  • VABK N/A
  • AVG Volume (30 Days)
  • RCEL 201.7K
  • VABK 5.4K
  • Earning Date
  • RCEL 05-08-2025
  • VABK 04-25-2025
  • Dividend Yield
  • RCEL N/A
  • VABK 3.80%
  • EPS Growth
  • RCEL N/A
  • VABK N/A
  • EPS
  • RCEL N/A
  • VABK 3.15
  • Revenue
  • RCEL $64,251,000.00
  • VABK $53,661,000.00
  • Revenue This Year
  • RCEL $62.33
  • VABK N/A
  • Revenue Next Year
  • RCEL $30.59
  • VABK N/A
  • P/E Ratio
  • RCEL N/A
  • VABK $10.99
  • Revenue Growth
  • RCEL 28.14
  • VABK N/A
  • 52 Week Low
  • RCEL $6.90
  • VABK $24.06
  • 52 Week High
  • RCEL $14.16
  • VABK $44.00
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 56.76
  • VABK 42.47
  • Support Level
  • RCEL $8.15
  • VABK $34.66
  • Resistance Level
  • RCEL $9.36
  • VABK $35.02
  • Average True Range (ATR)
  • RCEL 0.67
  • VABK 1.09
  • MACD
  • RCEL 0.15
  • VABK -0.17
  • Stochastic Oscillator
  • RCEL 93.90
  • VABK 12.69

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses and charitable organizations.

Share on Social Networks: